Here's the latest variant picture for Western Australia.
XBB.1.16.* "Arcturus" (35%) has rebounded to displace the "Deltacron" XBC.* variant (19%).
The new EG.5.* "Eris" variant (12%) is growing - it's growth advantage of 4% per day over XBB.1.16.* predicts a crossover in early August.
Sample volumes look representative up to July 28.
#COVID19 #WA #XBB_1_16 #Arcturus #XBC #Deltacron #EG_5 #Eris @auscovid19
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
#COVID19 #wa #xbb_1_16 #arcturus #xbc #Deltacron #eg_5 #eris
Here's the latest variant picture for Japan.
The new EG.5.* "Eris" variant (19%) has been rising steadily to challenge XBB.1.16.* "Arcturus" (24%) and XBB.1.9.* "Hyperion" (21%).
The sample volumes seem representative up to July 19.
#COVID19 #japan #xbb_1_16 #arcturus #eg_5 #eris
Here's the latest variant picture for New Zealand.
XBB.1.5.* "Kraken" (28%) has rebounded to overtake CH.1.1.* "Orthrus" (25%). XBB.1.16.* "Arcturus" (16%) and XBB.1.9.* "Hyperion" (19%) are still significant.
The new EG.5.* variant (5%) is present and growing, but is not significant yet.
The vigorous mix of variants implies increased immediate reinfection risks for those relying on immunity from a prior infection. Every variant is a minority of the recent samples.
The sample volumes seem representative up to July 10.
#COVID19 #NZ #XBB_1_5 #Kraken #CH_1_1 #Orthrus #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion
🧵
#COVID19 #nz #xbb_1_5 #kraken #ch_1_1 #orthrus #xbb_1_16 #arcturus #xbb_1_9 #hyperion
Here's the latest variant picture for Western Australia.
"Deltacron" XBC.* (31%) and XBB.1.16.* "Arcturus" (31%) are the leading variants in a messy soup.
Among the individual lineages, there was recent growth in XBB.1.9.1 (12%) - a "Hyperion" sub-lineage.
The XBC.1.3 sub-lineage (14%) is the most common from that variant, vs XBC.1.6.* in South Australia.
The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to July 6.
#COVID19 #Australia #QLD #Brisbane #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBC #Deltacron @auscovid19
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
#COVID19 #australia #qld #brisbane #xbb_1_16 #arcturus #xbb_1_9 #hyperion #xbc #Deltacron
Here's the latest variant picture for New South Wales, Australia.
XBB.1.9.* "Hyperion" (29%) and XBB.1.16.* "Arcturus" (28%) are the leading variants in a messy soup.
Among the individual lineages, there was recent growth in XBB.1.16.2 (11%).
The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to July 4.
#COVID19 #Australia #NSW #Sydney #XBB_1_9 #Hyperion #XBB_1_16 #Arcturus @auscovid19
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
#COVID19 #australia #nsw #sydney #xbb_1_9 #hyperion #xbb_1_16 #arcturus
Here's the latest variant picture for New Zealand.
CH.1.1.* "Orthrus" (36%) rebounded to a leading position, in a close contest with XBB.1.16.* "Arcturus" (29%) and XBB.1.9.* "Hyperion" (29%).
The vigorous mix of variants implies increased immediate reinfection risks for those relying on immunity from a prior infection. Every variant is a minority of the recent samples.
The sample volumes seem representative up to June 22. Unfortunately, the update cycle for NZ seems to have fallen back to once a month. Any successful new variant will likely already be widespread by the time it appears in this data. More timely summarised frequencies are shared weekly (not via GISAID), but for a very limited set of variants.
#COVID19 #NZ #CH_1_1 #Orthrus #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion
🧵
#COVID19 #nz #ch_1_1 #orthrus #xbb_1_16 #arcturus #xbb_1_9 #hyperion
Here's the latest variant picture for New South Wales, Australia.
"Deltacron" XBC.* (23%) is rising sharply to challenge the dominance of XBB.1.16.* "Arcturus" (29%).
XBB.2.3.* "Acrux" (15%) is also rising quite rapidly.
The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to June 19.
#COVID19 #Australia #NSW #Sydney #XBC #Deltacron #XBB_2_3 #Acrux #XBB_1_16 #Arcturus @auscovid19
🧵
#COVID19 #australia #nsw #sydney #xbc #Deltacron #xbb_2_3 #acrux #xbb_1_16 #arcturus
Here's the latest variant picture for Victoria.
XBB.1.16.* "Arcturus" (34%) is taking it's turn to dominate, following XBB.1.9.* "Hyperion" (24%).
XBB.1.5.* "Kraken" (13%) has been declining steadily.
The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
#COVID19 #Australia #VIC #Melbourne #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBB_1_5 #Kraken @auscovid19
🧵
#COVID19 #australia #Vic #melbourne #xbb_1_16 #arcturus #xbb_1_9 #hyperion #xbb_1_5 #kraken
Here's the latest variant picture for the United Kingdom.
XBB.1.9.* "Hyperion" (39%) is driving the current wave, taking over from XBB.1.5 "Kraken" (26%).
XBB.1.16.* "Arcturus" (21%) is also rising.
The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
#COVID19 #uk #xbb_1_9 #hyperion #xbb_1_16 #arcturus
Here's the latest variant picture for the Australian Capital Territory (ACT).
XBB.1.9.* "Hyperion" (29%) and CH.1.1.* "Orthrus" (29%) are battling for dominance.
XBB.1.16.* "Arcturus" (18%) and "Deltacron" XBC.* (13%) are still quite significant.
The chaotic mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to June 1.
#COVID19 #Australia #ACT #Canberra #FK_1_1 #CH_1_1 #Orthrus #XBB_1_16 #Arcturus @auscovid19
#COVID19 #australia #act #canberra #fk_1_1 #ch_1_1 #orthrus #xbb_1_16 #arcturus
Here's the latest variant picture for Western Australia.
XBB.1.9.* "Hyperion" (40%) and XBB.1.16.* "Arcturus" (31%), appear to be battling for dominance
The sample volumes seem representative up to June 1.
#COVID19 #Australia #WA #Perth #XBB_1_9 #Hyperion #XBB_1_16 #Arcturus @auscovid19
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
#COVID19 #australia #wa #perth #xbb_1_9 #hyperion #xbb_1_16 #arcturus
Here's the latest variant picture for Queensland, Australia.
It's difficult to interpret as sample volumes are very low and patchy. There's a lengthy gap where <10 samples were shared, between May 13 and May 24.
XBB.1.9.* "Hyperion" (24%) may have returned to dominance. It looks like the many sub-lineages including EG.* and FL.* are making a contribution
#COVID19 #QLD #Brisbane #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBB_1_5 #Kraken @auscovid19
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
#COVID19 #qld #brisbane #xbb_1_16 #arcturus #xbb_1_9 #hyperion #xbb_1_5 #kraken
Here's the latest variant picture for New South Wales, Australia.
XBB.1.16.* "Arcturus" (32%) is taking it's turn to dominate, following XBB.1.9.* "Hyperion" (25%).
XBB.1.5.* "Kraken" (14%) has been declining steadily.
Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.
The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to June 5.
#COVID19 #Australia #NSW #Sydney #XBB_1_9 #Hyperion #XBB_1_5 #Kraken #XBB_1_16 #Arcturus @auscovid19
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
#COVID19 #australia #nsw #sydney #xbb_1_9 #hyperion #xbb_1_5 #kraken #xbb_1_16 #arcturus
Here's the latest variant picture for Victoria.
XBB.1.16.* "Arcturus" (34%) is taking it's turn to dominate, following XBB.1.9.* "Hyperion" (24%).
XBB.1.5.* "Kraken" (12%) has been declining steadily.
Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.
The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to June 5.
#COVID19 #Australia #VIC #Melbourne #XBB_1_9 #Hyperion #XBB_1_5 #Kraken #XBB_1_16 #Arcturus @auscovid19
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
#COVID19 #australia #Vic #melbourne #xbb_1_9 #hyperion #xbb_1_5 #kraken #xbb_1_16 #arcturus
Here's the latest variant picture for Western Australia.
The XBC.* Deltacron variant clan (31%) appears to have surged to dominance, although recent samples are a bit patchy.
You could throw a blanket over XBB.1.16.* "Arcturus" (20%), XBB.1.9.* "Hyperion" (19%) and CH.1.1.* "Orthrus" (17%) variants.
XBB.1.5.* "Kraken" (9%) is still significant, along with XBB.2.3.* "Acrux" (9%).
The variant mix in WA continues to be uniquely chaotic, reflecting its situation as a global crossroads. Even WA residents who've been racking up regular reinfections are likely to meet new variants capable of overcoming their immunity. Four variants are at 17%+ frequency, with another two around 10%.
The sample volumes seem representative up to May 16.
#COVID19 #Australia #WA #Perth #XBC #Deltacron #XBB_1_9 #Hyperion #XBB_1_5 #Kraken #XBB_1_16 #Arcturus #CH_1_1 #Orthrus @auscovid19
🧵
#COVID19 #australia #wa #perth #xbc #Deltacron #xbb_1_9 #hyperion #xbb_1_5 #kraken #xbb_1_16 #arcturus #ch_1_1 #orthrus
Here's the latest variant picture for Switzerland.
XBB.1.5.* "Kraken" (42%) and XBB.1.9.* "Hyperion" (37%) have been dueling for dominance.
XBB.1.16.* "Arcturus" (23%) is rising sharply, and will be the next to challenge.
Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.
The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to May 5.
#COVID19 #Switzerland #XBB_1_16 #Arcturus #XBB_1_5 #Kraken #XBB_1_9 #Hyperion
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
#COVID19 #switzerland #xbb_1_16 #arcturus #xbb_1_5 #kraken #xbb_1_9 #hyperion
Here's the latest variant picture for the United Kingdom.
XBB.1.5.* "Kraken" (40%) has been declining steadily.
The challenge from XBB.1.9.* "Hyperion" (24%) appears to be fading.
XBB.1.16.* "Arcturus" (22%) has been growing steadily.
Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.
The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem somewhat representative up to May 18, although the volume appears to be declining, unfortunately.
#COVID19 #UK #XBB_1_5 #Kraken #XBB_1_9 #Hyperion #XBB_1_16 #Arcturus
🧵
#COVID19 #uk #xbb_1_5 #kraken #xbb_1_9 #hyperion #xbb_1_16 #arcturus
Here's the latest variant picture for Japan.
XBB.1.16.* "Arcturus" (30%) seems to have taken over dominance from XBB.1.9.* "Hyperion" (25%).
XBB.1.5.* "Kraken" (20%) is still significant.
XBB.2.3.* "Acrux" (7%) is rising, and might be the next to challenge.
Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.
The vigorous mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to May 8.
#COVID19 #Japan #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
#COVID19 #japan #xbb_1_16 #arcturus #xbb_1_9 #hyperion
Here's the latest variant picture for Singapore.
XBB.2.3.* "Acrux" (33%) and XBB.1.16.* "Arcturus" (30%) are battling for dominance.
XBB.1.9.* "Hyperion" (23%) has rebounded during May.
Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.
The vigorous mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to May 23.
#COVID19 #Singapore #XBB_1_16 #Arcturus #XBB_2_3 #Acrux
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
#COVID19 #singapore #xbb_1_16 #arcturus #xbb_2_3 #acrux
Here's the latest variant picture for Malaysia.
XBB.1.16.* "Arcturus" (39%) now looks dominant over XBB.1.9.* "Hyperion" (22%).
XBB.2.3.* "Acrux" (11%) is rising, and might be the next to challenge.
Be alert for conjunctivitis symptoms, particularly associated with the Arcturus variant.
The mix of very different variants poses a raised immediate re-infection risk for anyone relying on natural immunity from a recent infection.
The sample volumes seem representative up to May 18, but look a bit patchy.
#COVID19 #Malaysia #XBB_1_16 #Arcturus #XBB_1_9 #Hyperion #XBB_2_3 #Acrux
Interactive genomic sequencing dataviz, code, acknowledgements and more info here:
https://github.com/Mike-Honey/covid-19-genomes#readme
#COVID19 #malaysia #xbb_1_16 #arcturus #xbb_1_9 #hyperion #xbb_2_3 #acrux